Skip to content
2000
Volume 11, Issue 1
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

The renin-angiotensin-aldosterone system (RAAS) plays pivotal roles in the pathogenesis of progression of arterial hypertension, chronic kidney disease (CKD) and cardiovascular disease (CVD). Previous studies suggested that a direct renin inhibitor, aliskiren, may be effective for blood pressure lowering, renoprotection and cardiovascular protection. This review focuses on the effects of aliskiren for arterial hypertension, CKD and CVD.

Loading

Article metrics loading...

/content/journals/chamc/10.2174/1871525711311010012
2013-03-01
2025-12-07
Loading full text...

Full text loading...

/content/journals/chamc/10.2174/1871525711311010012
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test